Biovie (BIVI) Other Non-Current Liabilities (2017 - 2024)
Biovie (BIVI) recorded Other Non-Current Liabilities of $7,290 in fiscal Q2 2025 (quarter ended Dec 31, 2024), down 94.4% from $129,706 a year earlier but up 481.3% from the prior quarter.
Powered by 
Analysis
Biovie (BIVI) Other Non-Current Liabilities (2017 - 2024) Analysis & Trends
At the end of FY2024 (ended Jun 30, 2024), Biovie reported Other Non-Current Liabilities of $3,771, down 99.8% from FY2023.
- Annual Other Non-Current Liabilities has a four-year compound annual growth rate of -88.5% (FY2020 to FY2024).
- Across earlier fiscal years, Other Non-Current Liabilities came in at $1.82 million in FY2023 (+40.0%), $1.3 million in FY2022 and $21.41 million in FY2020.
- Quarterly Other Non-Current Liabilities has ranged from $1,254 in fiscal Q1 2025 to $21.41 million in fiscal Q4 2020 over the past five years.
- On a year-over-year basis, Other Non-Current Liabilities has declined for five consecutive quarters, with an average decline of 43.9% over the last eight quarters.
- Peak year-over-year performance for Other Non-Current Liabilities in the last five years was growth of 97.2% in fiscal Q2 2023, against a decline of 99.9% in fiscal Q1 2025 at the low end.
- Per Business Quant, the preceding three fiscal quarters came in at $1,254 (Q1 2025), $3,771 (Q4 2024) and $48,000 (Q3 2024).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Biovie | 11.46 Mn | 11.46 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2024 | 7,290.00 |
| Sep 30, 2024 | 1,254.00 |
| Jun 30, 2024 | 3,771.00 |
| Mar 31, 2024 | 48,000.00 |
| Dec 31, 2023 | 129,706.00 |
| Sep 30, 2023 | 1.11 Mn |
| Jun 30, 2023 | 1.82 Mn |
| Mar 31, 2023 | 4.54 Mn |
| Dec 31, 2022 | 4.17 Mn |
| Sep 30, 2022 | 949,103.00 |
| Jun 30, 2022 | 1.30 Mn |
| Mar 31, 2022 | 2.50 Mn |
| Dec 31, 2021 | 2.11 Mn |
| Sep 30, 2021 | 483,854.00 |
| Jun 30, 2020 | 21.41 Mn |
| Mar 31, 2020 | 2.88 Mn |
| Dec 31, 2019 | 3.25 Mn |
| Sep 30, 2019 | 10.64 Mn |
| Mar 31, 2017 | 575,917.00 |
API Access
Biovie Other Non-Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=BIVI&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-non-current-liabilities", "ticker": "BIVI", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=BIVI&period=max&api_key=YOUR_API_KEY");
const data = await res.json();